What is the price-to-earnings ratio of Paion?
The price-earnings ratio of Paion is currently -0.18.
Paion P/E 2024
Paion P/E
-0.18
Ticker
PA8.DE
ISIN
DE000A0B65S3
WKN
A0B65S
As of Sep 17, 2024, Paion's P/E ratio was -0.18, a -92.59% change from the -2.43 P/E ratio recorded in the previous year.
The Paion P/E history
Paion Aktienanalyse
What does Paion do?
Paion AG is a German pharmaceutical company based in Aachen. The company was founded in 2000 by four partners, including current CEO Dr. Wolfgang Söhngen. Since its founding, Paion has specialized in developing and marketing medications for sedation and anesthesia. In 2005, the company received approval for its first product, Remimazolam, a short-acting benzodiazepine that induces unconsciousness and is used in anesthesia and diagnostics. The medication has been on the market in Europe since 2020. Paion's business model is based on developing innovative medications that meet a high medical need and can succeed in the market. The company relies on intensive collaboration with its partners, including major pharmaceutical companies such as Mundipharma and Cosmo Pharmaceuticals. Paion develops its products until they are ready for the market and then transfers the marketing to its partners, allowing the company to fully focus on research and development of new medications. Over the years, Paion AG has specialized in various areas. In addition to anesthesia and sedation, the company has also made progress in neurology and oncology. Currently, Paion is developing a new medication for traumatic brain injury, which has already shown promising results in clinical trials. Another project involves the development of a treatment for lung cancer, which is also being tested in the clinical phase. Overall, Paion AG operates in various sectors and relies on close collaboration with its partners. The products offered by the company are all aimed at providing a high medical benefit and playing an important role in patient care. Paion is a dynamic company with a clear focus on innovation and growth. The health and well-being of patients are always a top priority. With its broad portfolio of innovative medications and successful collaboration with its partners, the company is well positioned to continue playing an important role in the market and expand its position as a leading provider of sedatives and anesthetics. Paion ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Paion's P/E Ratio
The Price to Earnings (P/E) Ratio of Paion is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Paion's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Paion is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Paion’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Paion stock
How has the price-earnings ratio of Paion changed compared to last year?
The price-to-earnings ratio of Paion has increased by -92.59% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Paion high compared to other companies?
Yes, the price-to-earnings ratio of Paion is high compared to other companies.
How does an increase in the price-earnings ratio of Paion affect the company?
An increase in the price-earnings ratio of Paion would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Paion affect the company?
A decrease in the price-earnings ratio of Paion would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Paion?
Some factors that influence the price-earnings ratio of Paion are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Paion pay?
Over the past 12 months, Paion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Paion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Paion?
The current dividend yield of Paion is .
When does Paion pay dividends?
Paion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Paion?
Paion paid dividends every year for the past 0 years.
What is the dividend of Paion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Paion located?
Paion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Paion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Paion from 9/17/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Paion pay the last dividend?
The last dividend was paid out on 9/17/2024.
What was the dividend of Paion in the year 2023?
In the year 2023, Paion distributed 0 EUR as dividends.
In which currency does Paion pay out the dividend?
The dividends of Paion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Paion stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Paion
Our stock analysis for Paion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
